Funds are available to support innovative, investigator-initiated studies that have potential to develop into clinical trials related to either Precision Medicine or COVID-19.

TriNetX at UTMB Health provides researchers the ability to explore a limited de-identified set of patient data. This tool is most useful for identification of patient cohorts in preparation for research.